| Title |
Date |
| Key Fat And Cholesterol Cell Regulator Identified, Promising Target |
09/01/06 |
|
Researchers at Harvard Medical School and Massachusetts General Hospital have identified how a molecular switch regulates fat and cholesterol production, a step that may help advance treatments for metabolic syndrome, the constellation of diseases that |
| U.S. Appeals Court Upholds Lipitor's Basic Patent With Exclusivity Maintained In U.S. Until March, 2010 |
09/01/06 |
|
Pfizer Inc said today that a panel of the Court of Appeals for the Federal Circuit has upheld the exclusivity of the main patent covering atorvastatin, the active ingredient in Lipitor, maintaining patent protection for Lipitor in the U.S. until March 20 |
| Researchers Develop Risk Predictor For Dementia |
09/01/06 |
|
A team of researchers have developed a new method to predict dementia risk that could help to identify individuals who might benefit from intensive lifestyle consultations and drug interventions. They published their findings online in The Lancet Neuro |
| Geisinger Researchers Discover Ability Of Statins To Help Control Danger Of Abdominal Aortic Aneurysms |
09/01/06 |
|
Researchers working at Geisinger
Medical Center and The Sigfried Janet Weis Center for Research in Danville,
Pennsylvania, have found that statins, one of the most commonly prescribed
cholesterol lowering agents, can control the growth of abdominal a |
| USA Today Examines Access, Cost Issues For Lipitor After Generic Zocor Launch |
09/01/06 |
|
USA Today on Monday examined how some U.S. residents have begun to find that the anti-cholesterol medication Lipitor, manufactured by Pfizer, is "harder and more expensive to get" as employers encourage use of generic medications to reduce prescription |
| LXR Alpha: A New StAR In Balancing Cholesterols Levels In The Adrenal Gland |
09/01/06 |
|
Cholesterol is the precursor to all steroid hormones, which control heart rate, blood pressure, and how the body utilizes food. Therefore a constant cholesterol supply must be available to the adrenal gland where such hormones are produced. Liver X rec |
| Schering-Plough, GlaxoSmithKline Study Further Validates MediSys Corporation's MaxLife Center For Men(TM) |
09/01/06 |
|
MediSys
Corporation (Pink Sheets: MDYS) cited a recently published news release of
a study commissioned by SCHERING-PLOUGH and GLAXO SMITH KLINE, the makers
of Levitra(R), that shows a clear indication that The MaxLife Center For
Men(TM) system has b |
| Generic Availability Of Zocor(R) And Zoloft(R) Will Create Significant Cost Savings For Consumers |
09/01/06 |
|
Two popular prescription drugs
are about to become available as generics, reaping significant savings on
prescription drug costs for consumers and employers who purchase health
plans. |
| Ranbaxy Receives USFDA Approval To Market 80mg Simvastatin Tablets With 180-Day Exclusivity |
09/01/06 |
|
Ranbaxy Laboratories Limited (RLL), announced today that the Company has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Simvastatin Tablets USP, 80mg with 180-day exclusivity in the U.S. The FDA's Office of G |
| Biggest LDL-C Reduction Ever Shown In Patients Is Achieved With A CRESTOR Combination Therapy |
09/01/06 |
|
A combination treatment regimen of CRESTORTM (rosuvastatin) 40 mg and ezetimibe 10 mg achieved an unprecedented 70 per cent reduction in LDL-C which is the largest reduction in LDL-C ever seen in a statin clinical trial. In just six weeks, this combinati |
| Ranbaxy Receives FDA Approval To Market Simvastatin 80mg Tablets With 180-Day Exclusivity |
09/01/06 |
|
Ranbaxy Pharmaceuticals Inc.
(RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL),
announced today that the company has received approval from the U.S. Food
and Drug Administration (FDA) to manufacture and market Simvastatin Tablets |
